These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7525881)

  • 1. Structural comparison of NK2 receptor agonists and antagonists.
    Giolitti A; Maggi CA
    J Comput Aided Mol Des; 1994 Jun; 8(3):341-4. PubMed ID: 7525881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conformational analysis of tachykinins. II. N-terminal fragments of phyllomedusin, eledoisin, kassinin, and neurokinins].
    Avanov AIa
    Bioorg Khim; 1991 Jun; 17(6):747-55. PubMed ID: 1663744
    [No Abstract]   [Full Text] [Related]  

  • 5. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of C-terminally substituted tachykinin-like peptide agonists by means of aequorin-based luminescent assays for human and insect neurokinin receptors.
    Torfs H; Detheux M; Oonk HB; Akerman KE; Poels J; Van Loy T; De Loof A; Vassart G; Parmentier M; Vanden Broeck J
    Biochem Pharmacol; 2002 May; 63(9):1675-82. PubMed ID: 12007570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
    Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of residues involved in ligand binding to the neurokinin-2 receptor.
    Huang RR; Vicario PP; Strader CD; Fong TM
    Biochemistry; 1995 Aug; 34(31):10048-55. PubMed ID: 7543277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat.
    Lördal M; Bränström R; Hellström PM
    Br J Pharmacol; 1998 Jan; 123(1):63-70. PubMed ID: 9484855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of both NK1 and NK2 receptors in guinea-pig airways.
    McKee KT; Millar L; Rodger IW; Metters KM
    Br J Pharmacol; 1993 Oct; 110(2):693-700. PubMed ID: 7694756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK(2) receptors.
    Kerr KP; Thai B; Coupar IM
    Br J Pharmacol; 2000 Dec; 131(7):1461-7. PubMed ID: 11090121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
    Broccardo M; Improta G; Tabacco A
    Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
    Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
    Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma extravasation induced by neurokinins in conscious rats: receptor characterization with agonists and antagonists.
    Nicolau M; Sirois MG; Bui M; Plante GE; Sirois P; Regoli D
    Can J Physiol Pharmacol; 1993; 71(3-4):217-21. PubMed ID: 7691388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence that tachykinin-induced contraction of human isolated bronchus is mediated only by NK2-receptors.
    Sheldrick RL; Rabe KF; Fischer A; Magnussen H; Coleman RA
    Neuropeptides; 1995 Nov; 29(5):281-92. PubMed ID: 8587664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tachykinins and capsaicin on the mechanical and electrical activity of the guinea-pig isolated trachea.
    Girard V; Félétou M; Advenier C; Canet E
    Br J Pharmacol; 1997 Nov; 122(5):841-8. PubMed ID: 9384499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices.
    Seabrook GR; Bowery BJ; Hill RG
    Eur J Pharmacol; 1995 Jan; 273(1-2):113-9. PubMed ID: 7537676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
    Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
    Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonist.
    Gerspacher M; von Sprecher A; Mah R; Anderson GP; Bertrand C; Subramanian N; Hauser K; Ball HA
    Bioorg Med Chem Lett; 2000 Jul; 10(13):1467-70. PubMed ID: 10888334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.